CANBRIDGE-B (01228) granted a total of approximately 6.3726 million share options and 6.3726 million restricted share units.
North Sea Kangcheng-B (01228) announced that on January 12, 2026, the company granted a total of 6,372,575 share options to 30 option grantees under the first public offering after the rights issue plan, and granted a total of 6,372,575 restricted share units to 28 restricted share unit grantees under the plan of restricted share units after the first public offering. The exercise price of the granted share options is HKD 2.32 per share.
CANBRIDGE-B (01228) announced that on January 12, 2026, the company granted a total of 6,372,575 share options to 30 option grantees under the first public offering after the Stock Right Plan, and granted a total of 6,372,575 restricted share units to 28 restricted share unit grantees under the first public offering after the Restricted Share Unit Plan. The exercise price of the share options granted is HK$2.32 per share.
Related Articles

BitGo (BTGO.US) is sprinting towards an IPO! Seeking to raise up to $201 million - potentially becoming the first publicly listed cryptocurrency company this year.

NVIDIA Corporation (NVDA.US) partners with Eli Lilly (LLY.US) to increase investment in AI pharmaceuticals, with a five-year $1 billion commitment to jointly build a Silicon Valley joint laboratory.

Paramount Sky (PSKY.US) intervenes to block the trade of Netflix (NFLX.US), planning to reorganize the board of Warner Bros. Discovery (WBD.US) and file a lawsuit.
BitGo (BTGO.US) is sprinting towards an IPO! Seeking to raise up to $201 million - potentially becoming the first publicly listed cryptocurrency company this year.

NVIDIA Corporation (NVDA.US) partners with Eli Lilly (LLY.US) to increase investment in AI pharmaceuticals, with a five-year $1 billion commitment to jointly build a Silicon Valley joint laboratory.

Paramount Sky (PSKY.US) intervenes to block the trade of Netflix (NFLX.US), planning to reorganize the board of Warner Bros. Discovery (WBD.US) and file a lawsuit.

RECOMMEND

Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026

Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026

“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026


